Name: Dong Yu
Academic Title: Professor
Email: yudong@suda.edu.cn
Address: 402-2312, North District of Dushu Lake Campus
Contact Phone: +86 512 65880052
I. Educational and Professional Experience
1. Educational Background：
(1) From April 1999 to March 2003, PhD in Radiation Therapy at Tokyo Medical and Dental University
(2) From October 1997 to March 1999, Tokyo Medical and Dental University, Molecular Genetics, Master's degree
(3) September 1989 to June 1994, Harbin Medical University, Department of Clinical Medicine, Bachelor's degree
2. Professional Experience
(1) From April 2012 to present, Professor at the School of Radiation Medicine and Protection, Soochow University
(2) From April 2010 to March 2012, Instructor, Radiation Therapy Department, Tokyo Medical and Dental University, Japan
(3) From April 2009 to March 2010, Researcher, Endocrinology Research Group, National Cancer Center of Japan
(4) From October 2006 to March 2009, Researcher, Heavy Ion Therapy Center of the National Institute of Radiation Medicine in Japan
(5) From October 2003 to September 2006, Researcher in Head and Neck Tumor Therapy at the Japan Association for the Promotion of Science and Technology
(6) From April 2003 to September 2003, Researcher in Molecular Tumor Therapy at Tokyo Medical and Dental University in Japan
II. Research Focus
1. Radiosensitivity
2. DNA damage and repair
3. Low dose radiation biological effects
II. Project
1. NSFC, The research on the biological effects and regulatory mechanisms of the new 17-AAG composite nanomedicine in radiation protection, 11475125, 980,000 RMB, 2015.01-2018.12
2. Jiangsu Provincial Natural Science Foundation, The spontaneous acquisition of radioresistance and its regulatory mechanism by IGF-IR deficient cells, BK20131165, 100,000 RMB, 2014.01-2015.12
IV. Academic Part-time Role
1. From January 2026 to present, Radiation Medicine and Protection, Editor
2. From August 2023 to present, Chinese Journal of Radiation Oncology, Editorial Board Member
V. Representative Research Outcomes
(1) Zhang N; Xue L; Yu D. Screening of differentially expressed miRNAs induced by 17-AAG-M in human NSCLC-A549 cells and their effect on radiosensitivity. Chinese Journal of Radiation Oncology, 2021, 30(6): 608-613 (corresponding author)
(2) Li, Zhongyang; Cai, Shang; Li, Huijun; Gu, Jincheng; Tian, Ye; Cao, Jianping; Yu, Dong; Tang, Zaixiang; Developing a lncRNA signature to predict the radiotherapy response of lower grade gliomas using co-expression and ceRNA network analysis, Frontiers in Oncology, 2021, 11: 622880 (co-corresponding author)
(3) Sai, Sei; Kim, Eun Ho; Vares, Guillaume; Suzuki, Masao; Yu, Dong; Horimoto, Yoshiya; Hayashi, Mitsuhiro; Combination of carbon-ion beam and dual tyrosine kinase inhibitor, lapatinib, effectively destroys HER2 positive breast cancer stem-like cells, American Journal of Cancer Research, 2020, 10(8): 2371-2386
(4) Liu, Qi; Guan, Jing-Zhi; Sun, Yong; Le, Ziyu; Zhang, Ping; Yu, Dong; Liu, Yong; Insulin-like growth factor 1 receptor-mediated cell survival in hypoxia depends on the promotion of autophagy via suppression of the PI3K/Akt/mTOR signaling pathway, Molecular Medicine Reports, 2017, 15(4): 2136-2142 (co-corresponding author)
(5) Xue L; Furusawa Y; Yu D; ATR signaling cooperates with ATM in the mechanism of low dose hypersensitivity-induced by carbon ion beam., DNA Repair, 2015, 34: 1-8 (corresponding author)